Capstone Therapeutics Corp. (CAPS)
(Delayed Data from NSDQ)
$1.18 USD
-0.17 (-12.59%)
Updated Oct 15, 2025 04:00 PM ET
After-Market: $1.18 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
Capstone Therapeutics Corp.'s dividend yield currently sits at 0%, which is in-line with the Building Products - Miscellaneous industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CAPS 1.18 -0.17(-12.59%)
Will CAPS be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for CAPS based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CAPS
Crossed Above 20 Day Moving Average appears for CAPS after 20.54% move
12 Industrials Stocks Moving In Wednesday's Pre-Market Session
Is CAPS primed for volatility? NR7 shows up after dropping 0.88%
Capstone Holding (CAPS) Achieves Early Success Post-Carolina Stone Integration
Capstone Therapeutics achieves milestones in Carolina Stone integration